Sponsor Pipeline

Lynk Pharmaceuticals Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07237568 A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis Ankylosing Spondylitis Recruiting
NCT06276998 A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA) Rheumatoid Arthritis Active, Not Recruiting
Disease Areas
Rheumatoid Arthritis (1) Ankylosing Spondylitis (1)
Get alerts when Lynk Pharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free